Companies: 10,795·Total market cap: $144.5T
Manhattan Scientifics, Inc.

Manhattan Scientifics, Inc.

MHTXOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$11186
P/E Ratio—
52W High$0.0001
52W Low$0.00002
Cash on HandFinancialsRevenue

Manhattan Scientifics, Inc. (MHTX) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

MHTX · cash on hand · updated Dec 31, 2023

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$67,000▼ -61.7% vs prior year
FY · as of Dec 31, 2023 · Reported in USD
Cash & Cash Equiv. (CCE)
$67,000
cashAndCashEquivalents
Short-Term Investments
$0
shortTermInvestments
YoY Change vs Prior Year
-61.7%
vs prior fiscal year
Latest Quarter
$38,000
Q2 2024
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2023

Net cash vs debt

Cash & ST Investments$67,000Cash on Hand
Total Debt$60,000Total Debt
Net Cash / Net Debt+$7,000Net Cash Position
Cash vs Debt Ratio
Cash 53%Debt 47%

Manhattan Scientifics, Inc. has a net cash position of $7,000, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$67,000 − $60,000 = +$7,000

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
MHTX annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Dec 31, 2023Latest$0.1M-61.7%
Dec 31, 2022$0.2M-24.6%
Dec 31, 2021$0.2M-34.3%
Dec 31, 2020$0.4M+35.2%
Dec 31, 2019$0.3M+200.0%
MHTX cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.6%#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
Manhattan Scientifics, Inc.
Manhattan Scientifics, Inc.YOU
MHTX
$0.1M599.0%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Manhattan Scientifics, Inc. (MHTX) cash on hand as of December 31, 2023 is $67,000, comprising $67,000 in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as Manhattan Scientifics, Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Manhattan Scientifics, Inc. cash reserves or cash position.

Manhattan Scientifics, Inc. annual cash on hand history shows decreased -61.7% in 2023: decreased -61.7% in 2023. Manhattan Scientifics, Inc. cash reserves in 2023 reflect the company's capital allocation strategy.

Manhattan Scientifics, Inc. carries total debt of $60,000 against cash of $67,000, resulting in a net cash position of +$7,000. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.
Financial statementsFree cash flowNet incomeRevenueMarket capP/E ratioEarningsPrice history

Frequently asked questions

MHTX cash on hand · 5 questions

As of December 31, 2023, Manhattan Scientifics, Inc. (MHTX) has $67,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $67,000 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (June 30, 2024): $38,000. Data sourced from the annual 10-K filing via FMP.

MHTX cash on handMHTX cash reservesMHTX cash 2023how much cash does MHTX have

▸ Source: FMP /balance-sheet-statement · US GAAP · Manhattan Scientifics, Inc. · Manhattan Scientifics, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2023